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Abstract
Background: Tubal sterilization is the method of family planning most commonly used. The
existence of the post-tubal-ligation syndrome of menstrual abnormalities has been the subject of
debate for decades.
Methods: In a cross-sectional study, 112 women with the history of Pomeroy type of tubal ligation
achieved by minilaparatomy as the case group and 288 women with no previous tubal ligation as
the control group were assessed for menstrual abnormalities.
Results: Menstrual abnormalities were not significantly different between the case and control
groups (p = 0.824). The abnormal uterine bleeding frequency differences in two different age
groups (30–39 and 40–45 years old) were statistically significant (p = 0.0176).
Conclusion: Tubal sterilization does not cause menstrual irregularities.
Background
Tubal sterilization is the most commonly used method of
family planning. In 1990 the corresponding percentage of
married women in reproductive age who used steriliza-
tion was 22% in developing countries and the corre-
sponding percentage in developed countries was 11%.
These women represented 44% and 18% of all contracep-
tive users in developing and developed countries, respec-
tively. Questions regarding the existence of a post tubal
ligation syndrome of menstrual abnormalities continue.
Questions arose initially when Williams and colleagues
reported in 1951 that sterilized women had a higher than
expected occurrence of menorrhagia and metrorrhagia
[1]. After that the existence of a post-tubal-ligation syn-
drome of menstrual abnormalities has been debated for
decades [2]. Many authors have investigated the sequelae
of female sterilization [2-9]. Increased premenstrual dis-
tress, heavier and more prolonged menstrual bleeding,
and increased dysmenorrhea have been reported [3].
However, failure to control for use of oral contraceptives,
age, obesity, parity, interval since sterilization, or type of
sterilization may have effects on the results of these stud-
ies [1,3]. Because of the importance of this debate, we
compared the occurrence of menstrual abnormalities in
women with and without a prior history of tubal ligation.
Methods
This cross sectional case control study has been carried out
on 500 women at Al-zahra hospital during 1999 to 2001
to assess the effect of tubal sterilization on the menstrual
cycle. 260 women with abnormal uterine bleeding
referred for diagnostic curettage, and 240 healthy women
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under the coverage of the hospital family planning center
were selected randomly, and all were assessed for tubal
ligation.
All women aged 30 to 46 were selected from a low-income
urban population, with body weight between 50 to 90 kg.
In the abnormal uterine bleeding group, those who had
intrauterine device (IUD), leiomyoma on sonography,
uterine size of greater than 9 cm or suffered from medical
disorders were excluded from the study. Of 260 patients
with menstrual irregularities, 30 subjects were excluded
from the study. From the remaining 230 subjects, assessed
for tubal sterilization, 87 patients had tubal ligation. Of
240 healthy women assessed for tubal ligation, 95 had
previous tubal ligation. Totally 182 subjects with previous
tubal ligation (case) and 288 subjects with no history of
previous tubal ligation (control) were compared for
abnormal uterine bleeding. Those subjects in the case
group who had menstrual abnormalities, IUD, medical
disorders or were on hormonal contraception, during the
first year prior to the sterilization were excluded from the
study. Those who were at least 30 and at most 40 years of
age by the time of tubal ligation and had Pomeroy type of
interval tubal ligation via minilaparatomy were included
the study. Finally, considering the exclusion and inclusion
criterias, 112 subjects remained in the case group and 288
with no tubal ligation in the control group were evaluated
for menstrual abnormalities. Information on demo-
graphic, obstetrics, medical and menstrual bleeding pat-
tern of all subjects were obtained. Women were asked
about the duration and amount of bleeding, and length of
cycle (number of days from the beginning of one men-
strual period to the beginning of the next one). A men-
strual interval of 21 to 35 days was considered normal. A
menstrual interval shorter than 21 days was defined as
polymenorrhea. Duration of flow of 7 days or less was
considered normal. A patient's self-described history of
normal or heavy blood loss was indicative of the amount
of flow. Regularly timed heavy bleeding and duration of
flow greater than 7 days were considered menorrhagia
and hypermenorrhea respectively. Excessive and pro-
longed bleeding that occurred irregularly was defined as
menometrorrhagia.
Data was analyzed by the SPSS statistical software (ver-
sion, 12) and compared with the chi-square test. P values
of 0.05 or less were considered as statistically significant.
Results
By considering the exclusion and inclusion criterias, 112
tubal ligated (case) and 288 non-tubal ligated subjects
(control) were evaluated for menstrual abnormalities. Of
112 subjects in the case group, 57 (50.8%) had menstrual
abnormalities. The corresponding figure in the control
group was 143, accounting for 49.6% of the studied sub-
jects in this group. The results of chi-square analysis, indi-
cate that there was no significant difference in the
menstrual abnormalities between two groups, χ 2 = 0.050,
p = 0.824.
The highest frequency of the menstrual abnormalities in
the case group was 54.3% for the group aged between 30–
39 while in the control group this value was 65% for those
aged 40–45. There was significant difference in the men-
strual abnormalities frequency of two groups by different
age groups, χ 2 = 9.06, p = 0.0176 (Table 1).
Type of abnormal bleeding is given in Figure 1. The most
common type of menstrual changes in case and control
groups was polymenorrhea (35%) and menorrhagy
(30%) respectively. The differences were not significant,
χ 2 = 6.93 p = 0.2260.
The frequency onset of abnormal bleeding after steriliza-
tion in the case group was 61% during the first year, 34%
in 2–5 years after sterilization and 5% over 5 years.
The menstrual abnormality frequency distributions by
different parity groups in the case and control groups are
shown in Table 1. The most common menstrual abnor-
Table 1: Demographic and obstetrical information of subjects with menstrual irregularities in case and control groups
(57) case group (143) control group df pv
No. (%) No. (%)
Age groups(year):
30–39 31(54.3) 50(34.96) 1 0.0176819
40–45 26(45.6) 93(65.1)
Parity groups (No.):
2–4 8(14) 31(22) 2 0.3819013
5–7 28(50) 58(40)
>7 21(36) 54(38)BMC Women's Health 2005, 5:5 http://www.biomedcentral.com/1472-6874/5/5
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malities frequency which belonged to parity of 5–7, was
50% and 40% in case and control groups respectively. The
parity differences between two groups were not signifi-
cant, χ 2 = 1.93 p = 0.3819.
The most common histologic findings in case and control
groups were proliferative endometrium 31.6% and ano-
vulatory cycle (28.7%) respectively. There was no signifi-
cant difference in the histologic finding of two groups, χ 2
= 5.351, p = 0.253.
Discussion
There are some factors other than sterilization per se that
may have influences on post sterilization menstrual
changes. Two such factors are the use of oral contracep-
tives and IUD. The women who use oral contraceptive
may have some menstrual changes after sterilization
attributable solely to cessation of oral contraceptive use.
In order to exclude the interventional effect of IUD and
oral contraceptive, we included patients who did not use
them during one year before sterilization. Since the type
of tubal sterilization may have effects on study results, we
included only Pomeroy type of interval sterilization by
minilaparatomy. The results are similar to those of Gen-
tile et al[3]., Bernard et al[4], Peterson et al[2], who
showed no significant changes in menstrual cycle charac-
teristics in women with or without tubal ligation. Con-
cerning the demographic information including the
socioeconomic status among the case and control groups,
all participants were of a low-income population. In the
unadjusted analysis, when the sterilized groups were com-
pared to the control group, slight but not statistically sig-
nificant changes were noted in menstrual indices. The
results are similar to those of Peterson et al[2],
Comparison of the menstrual irregularities type of case and control groups Figure 1
Comparison of the menstrual irregularities type of case and control groups
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Bhiwandiwala et al[11], who showed no menstrual pat-
tern changes following sterilization.
Although we had excluded patients who were on hormo-
nal contraceptives and had IUD, we found that most of
the menstrual changes occurred at first year of sterilization
(61%). After first year of sterilization the menstrual
changes decreased to 34% in 2–4 years and 5% after 5 or
more years of sterilization. The results are similar to those
of Parsanezhad et al[12], who found that almost all men-
strual changes occurred between 6 and 24 months after
sterilization. Thus it may be concluded that sterilization
related menstrual changes during the first years of sterili-
zation may occur due to some psychological reaction to
tubal ligation. DeStefano et al[13], in their long term fol-
low up of sterilized women found an increased risk of
menstrual abnormalities even after a long period of 49 to
87 months after sterilization. These late menstrual
changes are difficult to explain, because it is not easy to
postulate a physiologic mechanism that would take more
than 4 years to develop and adversely affect menstrual
cycles. Our results are dissimilar to those of Kasonde and
Bonnar[14] who did not find any increased menstrual
blood loss up to 6–12 months after sterilization. It seems
that different results of these studies may because
Kasonde and Bonnar objectively measured blood loss
whereas this study relied on subjective self reported
amounts of blood loss.
Shy et al[15] believe that menstrual changes effect of ster-
ilization depends on age at the time of sterilization.
Women who undergo sterilization between 20 and 29
years of age have more menstrual irregularities than
women who undergo the procedure after age 30. In order
to exclude this factor, we included only the patients with
at least 30 and at most 40 years of age by the time of ster-
ilization. The results show that the most common age
group of menstrual irregularities is 30–39 years (Table 1).
These results are similar to those of Wilcox et al[16] and
Shy et al[15] who found that sterilization at younger ages
leads to more menstrual irregularities than sterilization at
older ages.
Conclusion
Women who have undergone a Pomeroy type of tubal
ligation have no more menstrual abnormalities than
those without tubal ligation. Sterilization at younger ages
has more affect on menstrual irregularities than steriliza-
tion at older ages.
It seems that more frequency of menstrual changes at first
year of sterilization is due to other factors such as psychi-
atric problems. Further studies on psychiatric changes of
sterilization are mandatory to evaluate its effects on
immediate post sterilization menstrual irregularities.
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